awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37221249-5881C0E8-C034-40EE-B510-93BD66884132
Q37221249-5881C0E8-C034-40EE-B510-93BD66884132
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37221249-5881C0E8-C034-40EE-B510-93BD66884132
Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.
P2860
Q37221249-5881C0E8-C034-40EE-B510-93BD66884132
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37221249-5881C0E8-C034-40EE-B510-93BD66884132
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ca814da8e9d4a54e2970d28f4b6b617544c5fbe
P2860
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.